micro-community-banner
  • Saved

1yr
Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy - PubMed

Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/37870424/

Circulating lipoproteins may interact with platelets, increasing platelet sensitivity to aggregating agonists and their tendency towards activation and thrombus formation. In particular, patients with hypercholesterolemia exhibit a higher degree of...

Lipid-lowering therapies reduce platelet reactivity and thrombus formation, improving clinical outcomes. This review highlights the mechanisms, effects of various therapies, and emphasizes future research needs in optimizing platelet function management.

  • Saved

1yr
Background Image DesktopBackground Image Mobile

Mitochondrial DNA (mtDNA) plays a crucial role in cellular energy, and its maintenance is tied to lipid metabolism. Disruptions in lipid homeostasis can affect mtDNA integrity, leading to metabolic diseases. Targeting lipid trafficking and metabolism could offer new treatments for mitochondrial disorders.

Read More

  • Saved

1yr
Cardiovascular benefits of resistance exercise: It's time to prescribe

Cardiovascular benefits of resistance exercise: It's time to prescribe

Source : https://pubmed.ncbi.nlm.nih.gov/38703948/

Despite the well-known health benefits of regular physical activity, sedentary behavior and physical inactivity remain a real global pandemic. Exercise is associated with increased life expectancy, improved quality of life...

Resistance exercise is essential for cardiovascular health, offering benefits in strength, body composition, and disease management. Incorporating it into clinical practice enhances preventive strategies for cardiovascular risk.

  • Saved

1yr
Exploring the clinical effectiveness of glucagon-like peptide-1 receptor agonists in managing cardiovascular complications: an updated comprehensive review and future directives

Exploring the clinical effectiveness of glucagon-like peptide-1 receptor agonists in managing cardiovascular complications: an updated comprehensive review and future directives

Source : https://pubmed.ncbi.nlm.nih.gov/39359798/

The possible cardiovascular advantages of glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of drugs predominantly used to treat type 2 diabetes (T2D), have garnered increasing attention in recent years. Clinical...

GLP-1 receptor agonists demonstrate promise in managing type 2 diabetes and reducing cardiovascular risk, but further research is needed to optimize treatment regimens and enhance long-term patient outcomes.

  • Saved

1yr
Diet to Stop Hypertension: Should Fats be Included? - PubMed

Diet to Stop Hypertension: Should Fats be Included? - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38713264/

Since reducing salt consumption is an established recommendation only corollary dietary advice is subject to the current review. Population studies that have included reliable evaluation of fat intake have indicated...

Recent data suggest that reducing salt, incorporating marine oils, and following specific dietary patterns (e.g., plant-based, dairy, fat-adjusted) may help lower blood pressure, especially with weight reduction.